HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pharmacotherapy for cataplexy.

Abstract
A variety of medications representing several major drug classes improve cataplexy in patients with narcolepsy. These include aminergic reuptake inhibitors such as venlafaxine and clomipramine as well as sodium oxybate. This review is intended to familiarize readers with the safety and efficacy of these medications, thus enabling clinicians to optimize their management of cataplexy.
AuthorsWilliam C Houghton, Thomas E Scammell, Michael Thorpy
JournalSleep medicine reviews (Sleep Med Rev) Vol. 8 Issue 5 Pg. 355-66 (Oct 2004) ISSN: 1087-0792 [Print] England
PMID15336236 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't, Review)
Chemical References
  • Antidepressive Agents
  • Central Nervous System Stimulants
  • Cyclohexanols
  • Venlafaxine Hydrochloride
  • Sodium Oxybate
  • Clomipramine
Topics
  • Antidepressive Agents (adverse effects, therapeutic use)
  • Cataplexy (drug therapy)
  • Central Nervous System Stimulants (adverse effects, therapeutic use)
  • Clinical Trials as Topic
  • Clomipramine (adverse effects, therapeutic use)
  • Cyclohexanols (adverse effects, therapeutic use)
  • Humans
  • Long-Term Care
  • Sodium Oxybate (adverse effects, therapeutic use)
  • Treatment Outcome
  • Venlafaxine Hydrochloride

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: